Search

everythinglearnresearchcommunity

for

Search:↓

The PCL/PHB blend allows for slower, more controlled curcumin release than individual polymers.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

FOXA1 and CCL2 genes are more active in women with PCOS, varying by phenotype.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

EFFC might be common but underreported.

A new method accurately measures a drug in skin for cancer therapy research.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

FLCN helps control iron levels in cells.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Accurate diagnosis of EFFC is crucial for effective counseling and cosmetic care.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The new system helps detect and track early female hair loss better.

Finasteride may reduce prostate cancer risk.

Clouston syndrome is inherited in an autosomal dominant pattern and caused by a specific gene mutation, with no current treatment available.

A specific gene change plus an additional mutation in the same gene cause hereditary trichilemmal cysts.

Exprecell™ is as effective as traditional methods but produces more f-PRF and is simpler to use.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.